Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Article in Scientific Reports (February 2024)
The most recent citing publications are shown below. View all 75 publications that cite this research output on Dimensions.
Effectiveness and Safety of Originator and Biosimilar G-CSF as Primary Prophylaxis in DLBCL: A Cohort Study and Meta-Analysis
Preprint in Research Square (September 2023)
Prescription patterns of granulocyte colony–stimulating factors in patients with breast cancer: A real-world study
Article in PLOS ONE (July 2023)